![]() |
| HIV, the AIDS virus (yellow), infecting a human cell Image Credit: National Cancer Institute |
Scientific Frontline: "At a Glance" Summary: HIV Persistence in Myeloid Cells
- Main Discovery: HIV can persist for years in myeloid cells, specifically short-lived monocytes and longer-lived monocyte-derived macrophages, in individuals who have been virally suppressed on antiretroviral therapy.
- Methodology: Researchers isolated monocytes from the blood of virally suppressed participants and cultured them with antiretroviral drugs. After the monocytes differentiated into macrophages, an immune activating agent and fresh white blood cells were introduced to track viral reactivation and spread over a 12-day period using a novel quantitative method.
- Key Data: Detectable levels of HIV genetic material were found in the myeloid cells of 30 participants who had been on antiretroviral therapy for at least five years. Furthermore, cell cultures from 5 out of 10 participants demonstrated that the virus in these macrophages could reactivate, produce more virus, and infect new cells.
- Significance: The identification of myeloid cells as a long-lived and stable reservoir capable of viral rebound challenges the prevailing scientific consensus that monocytes are too short-lived to significantly impede HIV eradication efforts.
- Future Application: HIV cure strategies must be fundamentally broadened beyond their current scope to simultaneously target and eradicate viral reservoirs in both CD4 T cells and myeloid cells.
- Branch of Science: Virology and Microbiology
- Additional Detail: The study was led by researchers at the Johns Hopkins University School of Medicine, funded by the National Institutes of Health, and published in the journal Nature Microbiology.




.jpg)




.jpg)




